Impact BioMedical Inc. to Present at The Microcap Conference

Core Viewpoint - Impact BioMedical Inc. is actively participating in The Microcap Conference 2025 to showcase its growth strategy and investment opportunities [1][2]. Group 1: Company Participation - Frank D. Heuszel, the CEO of Impact BioMedical, will present at The Microcap Conference 2025, scheduled for January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ [1]. - The conference is recognized as a premier event for growth-focused companies and investors [1]. Group 2: Presentation Details - Heuszel will deliver a corporate presentation and hold one-on-one meetings with investors to discuss the company's recent developments and growth strategy [2]. - The presentation is set for January 29, 2025, at 10:30 AM ET [3]. Group 3: Company Overview - Impact BioMedical Inc. specializes in discovering, confirming, and patenting unique science and technologies for biopharmaceuticals and consumer healthcare [3]. - The company collaborates with external partners through research, licensing, co-development, joint ventures, and other relationships to develop new offerings [3].